World Bank gives $120m for Kenya’s vaccine facility
L-R: Kenya BioVax Institute CEO Dr Michael Lusiola, World Bank Vice President for Human Development Mamta Murthi and State Department for Medical Services Principal Secretary Harry Mutai when they toured Kenya BioVax Institute in Embakasi, Nairobi on February 7, 2024. PHOTO | EVANS HABIL | NMG
The World Bank has committed $120 million (Ksh19.1 billion at current exchange rates) to fund Kenya’s vaccine production facility, which is expected to start operations in 2029.
Health Principal Secretary (PS) Harry Kimutai disclosed the funding when he accompanied the World Bank Vice President for Human Development Mamta Murthi on her tour of the facility in Embakasi in Nairobi on Wednesday.
